Efficact and tolerability of a very low dose of Didanisine (ddl) compared ti a standard regimen

Christoph Stephan(Goethe University Frankfurt), Catherine Clumeck, Cécile Thioux, Bernadette Sommereijns, Jean‐Paul Van Vooren(Université Libre de Bruxelles)

Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)

January 1, 1993

Cited by 0

Related Papers

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

|Nature Medicine|1996|632

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

|The Lancet HIV|2023|506

Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients

|Antiviral Therapy|2005|133

CORRELATION AND PROGNOSTIC SIGNIFICANCE OF p53, p21 <sup>WAF1/CIP1</sup> AND Ki-67 EXPRESSION IN PATIENTS WITH SUPERFICIAL BLADDER TUMORS TREATED WITH BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPY

|The Journal of Urology|1999|124

Differential T and B Cell Responses against<i>Mycobacterium tuberculosis</i>Heparin‐Binding Hemagglutinin Adhesin in Infected Healthy Individuals and Patients with Tuberculosis

|The Journal of Infectious Diseases|2002|115